Superior vena cava syndrome radiation therapy

Jump to navigation Jump to search

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome radiation therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome radiation therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome radiation therapy

CDC on Superior vena cava syndrome radiation therapy

Superior vena cava syndrome radiation therapy in the news

Blogs on Superior vena cava syndrome radiation therapy

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome radiation therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Rapid radiotherapy is recommended for all patients who develop superior vena cava syndrome secondary to malignant tumor. The feasibility of radiation therapy depends on the stage of cancer at diagnosis. Radiation dosage will depend on clinical features.

Radiation Therapy

Most of the thoracic tumors causing superior vena cava syndrome are sensitive to radiotherapy. The majority of cases of superior vena cava syndrome are symptomatic and require radiation therapy for symptom relief.[1]

Indications

The feasibility of radiation therapy depends on the stage of cancer at diagnosis. If the obstruction caused by the SVCS is caused by a tumor that is not sensitive to chemotherapy, radiation therapy is indicated. [1]

Emergent RT

RT Dose/Schedule

  • Initially use high-dose fractions (3-4 Gy) for 2 or 3 days for curative treatment, followed by standard 1.8-2 Gy/fx
  • It is not unusual to palliate with 3Gy x 10, or 4Gy x 5, or 2.5Gy x 15
  • Symptomatic relief can be apparent in 72 hours, complete relief can be observed by 2 weeks (78% SCLC, 63% NSCLC)
  • Superior vena cava syndrome patency improvement only in 31% of the cases, so some symptomatic relief is probably due to the development of collateral circulation over time
  • Many patients will recur symptomatically prior to death
  • Consider chemotherapy before or with RT if:
    • SCLC, NHL, and germ cell tumors
    • In the absence of distant metastasis, aggressive management is indicated
    • Symptomatic relief within the first 30 days might be a good prognostic factor
    • Treatment with larger fractions of radiation is thought to be beneficial in developing a rapid response.

References

  1. 1.0 1.1 Wilson LD, Detterbeck FC, Yahalom J (2007). "Clinical practice. Superior vena cava syndrome with malignant causes". N. Engl. J. Med. 356 (18): 1862–9. doi:10.1056/NEJMcp067190. PMID 17476012.

Template:WH Template:WS